Abstract:The Wilms' tumor 1 (WT1) gene is one of the regulating factors in cell proliferation and development. It is a double-functional gene: an oncogene and a tumor suppressor. This gene was found to be highly expressed in many leukemic cell lines and in patients with acute myeloid leukemia. In the present study, we demonstrated that the WT1 gene was commonly expressed in leukemic cell lines apart from U937 cells. The K562 cell line which expresses WT1 at a high level (mRNA and protein) was used in the entire experiment. By MTT and colony formation assays, we found that curcumin, an inhibitor of the WT1 protein, inhibited cell proliferation and clonogenicity in a time- and dose-dependent manner. It also caused cell cycle arrest at the G2/M phase. We then designed specific short hairpin RNAs (shRNAs) which could downregulate WT1 by 70-80% at the mRNA and protein levels. Reduction in the WT1 levels attenuated the proliferative ability and clonogenicity. Cell cycle progression analysis indicated that the proportion of cells in the G0/G1 phase increased while the proportion in the S phase decreased distinctively. ChIP-DNA selection and ligation (DSL) experiment identified a cohort of genes whose promoters are targeted by WT1. These genes were classified into different cellular signaling pathways using MAS software and included the Wnt/β-catenin pathway, MAPK signaling pathway, apoptosis pathway, and the cell cycle. We focused on the Wnt/β-catenin signaling pathway, and compared expression of several genes in the K562 cells transfected with the control shRNA and WT1-specific shRNA. β-catenin, an important gene in the Wnt canonical pathway, was downregulated after WT1 RNAi. Target genes of β-catenin which participate in cell proliferation and cell cycle regulation, such as CCND1 and MYC, were also significantly downregulated. Collectively, these data suggest that WT1 functions as an oncogene in leukemia cells, and one important mechanism is regulation of the Wnt/β-catenin pathway.

The Wilms' Tumor 1 Gene: Oncogene or Tumor Suppressor Gene?

WT1 Mutation As a Cause of 46 XY DSD and Wilm’s Tumour: a Case Report and Literature Review

Physiological functions of Wilms' tumor 1-associating protein and its role in tumourigenesis.

Role of the Wilms' Tumor 1 Gene in the Aberrant Biological Behavior of Leukemic Cells and the Related Mechanisms.

The complex life of WT1

The Wilms Tumor Gene, Wt1 , is Required for Sox9 Expression and Maintenance of Tubular Architecture in the Developing Testis

Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth

Oxygen-Dependent Gene Expression in Development and Cancer: Lessons Learned from the Wilms’ Tumor Gene, WT1

The Functions Ofwt1in Mouse Gonad Development and Somatic Cells Differentiation

Research Progress on the Relationship among Wilms' Tumor-1 Gene and Its Coding Proteins and Tumor

Investigating the Dysfunctional Pathogenesis of Wilms' Tumor Through a Multidimensional Integration Strategy.

Wilms' tumor 1 gene in hematopoietic malignancies: clinical implications and future directions

The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism

Wilms' Tumor 1 And Signal Transducers And Activators Of Transcription 3 Synergistically Promote Cell Proliferation: A Possible Mechanism In Sporadic Wilms' Tumor

The development of Wilms tumor: from WT1 and microRNA to animal models.

ZMIZ1 Affects Invasion and Metastasis of Wilms Tumor by Regulating Notch Signaling Pathway

Expression of WT1 Gene in Nephroblastoma and Developing Kidneys

Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro

Overexpression of aquaporin-1 plays a vital role in proliferation, apoptosis, and pyroptosis of Wilms' tumor cells

The Tumor Suppressor WTX Shuttles to the Nucleus and Modulates WT1 Activity.

The Wilms Tumor Gene, Wt1, Maintains Testicular Cord Integrity by Regulating the Expression of Col4a1 and Col4a2